ImmunoPrecise Antibodies Investor Relations Material

ImmunoPrecise Antibodies Ltd. engages in antibody production and related services worldwide. It offers purification and affinity maturation of monoclonal antibodies; design, development, and validation of comprehensive service packages for the discovery of novel antibodies against therapeutic targets; custom peptide synthesis services; recombinant protein expression platforms; custom vaccines and neutralizing antibodies for passive transfer applications; and an in vivo passive transfer model for assessing the efficacy of passive immune treatments targeting infectious diseases.